Impact of higher hemoglobin targets on blood pressure and clinical outcomes: a secondary analysis of CHOIR

BACKGROUND: Targeting a higher hemoglobin in patients with chronic kidney disease leads to adverse cardiovascular outcomes, yet the reasons remain unclear. Herein, we sought to determine whether changes in erythropoiesis-stimulating agent (ESA) dose and in hemoglobin were predictive of changes in bl...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Inrig, Jula K., Sapp, Shelly, Barnhart, Huiman, Patel, Uptal D., Reddan, Donal, Singh, Ajay, Califf, Robert M., Szczech, Lynda
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2012
Matèries:
Clinical Science
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3433928/
https://ncbi.nlm.nih.gov/pubmed/22573238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfs123
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars